Immunologix Laboratories is featuring Dr. Michael Partridge from the 3rd Annual Immunologix Bioanalysis Symposium at Regeneron in Boston.
Public source
Publisher name
Public post
We're featuring another speaker from the 3rd Annual Immunologix Bioanalysis Symposium: Dr. Michael Partridge, Senior Director of Bioanalytical Sciences at Regeneron. Mic…
Company
Immunologix Laboratories
Focused. Experienced. Ready
- Industry
- Biotechnology Research
- Location
- Tampa, US
- Company size
- 51–200 employees
About Immunologix Laboratories
Immunologix Laboratories is a unique scientific partner, offering GLP and GCP compliant laboratory capabilities focused on ligand binding-based bioanalysis coupled with expert scientific consultation from our Translational Sciences team. Our laboratory specializes in Immunogenicity, Neutralizing Antibody (cell-based and ligand binding based), PK, and Biomarker assays in support of preclinical and clinical studies. Translational Sciences provides dedicated scientific resources to advise, develop and implement scientific strategies and practical solutions for innovator development programs. Our fully customizable approach includes delivering stage-appropriate biomarker & bioanalytical strategies, assay development and validation, study data interpretation, and support for regulatory interactions and filings. Our exceptional scientific experts work together as an integrated team ensuring that our client’s projects receive full benefit of the breadth and depth of experience gained over many decades within both contract laboratory and drug development organizations. The integration of Translational Sciences with the laboratory is unique within our industry and this confluence of expertise enables our team to deliver valuable scientific insights that accelerate decision making and the course of drug development. Please contact us at info@immunologixlabs.com
See moreLatest activity
Latest activity from Immunologix Laboratories
6 signals
Presence & Recognition
Immunologix Laboratories is hosting its October 1st lineup featuring Dr. Lauren Stevenson's talk on COU-Driven ADA Biomarker Assay Validation at Le Méridien Boston in Cambridge.
Presence & Recognition
Immunologix Laboratories hosted the 3rd Annual Immunologix Bioanalysis Symposium in Boston with a full FAQ put together to answer questions about the format, in-person attendance, and what's included.
Research & Knowledge
Immunologix Laboratories published a publication from CSL offering successful examples of regulator alignment and acceptance across multiple regulatory agencies using integrated data approaches to understand neutralizing activity.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
NewBiologix
NewBiologix is attending the Advanced Therapies Europe 2026 conference in Barcelona.
Presence & Recognition
Cambridge Healthtech Institute
Cambridge Healthtech Institute hosted an expert panel of scientists discussing immunotherapy clinical outcomes, resistance mechanisms, survival rates, prediction models, rational combinations, and extending to other indications.
Presence & Recognition
Crown Bioscience
Crown Bioscience researchers and drug discovery leaders are attending the Museum of Science, Boston on September 16 for an afternoon of cutting-edge science, meaningful connections, and translational research insights.
Presence & Recognition
Quanterix
Quanterix hosted a webinar exploring how researchers can build and optimize high-plex biomarker panels to support emerging hypotheses, incorporate new biomarkers, and generate deeper biological insights.
Presence & Recognition
RoukenBio